Nyxoah Highlights Positive Early Findings from Neurostimulator Trial for Sleep Apnea
The company has completed all 115 implants in the DREAM trial and expects full 12-month data in the first quarter of next year.
Category: Neurostimulators
Neurostimulators
Latest
Neurostimulators
Latest
Nyxoah Progresses in Neurostimulator Studies for Sleep Apnea
The clinical and regulatory milestones bring Nyxoah closer to offering its Genio neurostimulator solution to OSA patients in the US, according to the company.
Neurostimulators
Latest
Inspire Medical Invests in EnsoData & Ognomy
Inspire Medical Systems Inc has made equity investments in two private companies, EnsoData Inc in Wisconsin and Ognomy Inc in New York.
FDA Approves Nyxoah Genio 2.1 For Use in DREAM Pivotal Study for Obstructive Sleep Apnea
Genio 2.1’s upgrades are entirely related to the external components of the Genio system, as the implantable stimulator remains unchanged.
Read More
Inspire Medical Gains Momentum in US & Abroad During Q1
One key factor driving Inspire’s growth achieved during Q1 was the performance of the company’s Advisor Care Program.
Read More
Inspire Trialed in Children with Down Syndrome and Sleep Apnea
Children with Down syndrome and sleep apnea are more likely to experience aggressive behavior, brain fogging, and a loss of nearly 10 points in IQ compared to those without.
Read More
Years In, Neurostimulation for Sleep Apnea Keeps AHI Down
Neurostimulators don’t have decades of patient data like CPAP, but Inspire and remedē’s 1- and 5-year outcome studies show sustained benefits.
Read More
Inspire Surpasses 20,000 Patient Milestone for Its Implanted Neurostimulator for Sleep Apnea
Inspire achieved significant therapy utilization milestones in Q4 including the 20,000th patient being implanted with the device.
Read MoreInspire Medical Saw Sleep Apnea Device Sales Soar During 2021
Inspire Medical announced Tuesday that its 2021 revenue would be between $233 million and $233.4 million, a robust increase of about 102% over the previous year.
Read More
Neurostimulators Expand Opportunities for Sleep Practices
A second chance for many patients, devices like Inspire and remede also facilitate new avenues for marketing.
Read More
EXciteOSA, Daytime Sleep Apnea Therapy Device, Surpasses 50,000 Patient Session Milestone
“It was easy to find 20 minutes during the day to use it and the results have paid off. My husband now sleeps better without my snoring, and so do I.”
Read MoreSleep Research Society Focus Group on Non-CPAP Alternatives Now Available on YouTube
Moderated by Sairam Parthasarathy, MD, FAASM, the topic is particularly timely due to shortages of CPAP devices caused in part by the Philips CPAP/bilevel recall.
Read More
Inspire Launches Patient Experience Report
Inspire’s core objective with this report is to allow its customers to make informed decisions related to the best treatment options.
Read MoreMedicare Panel Recommends Increasing Payments for Inspire Therapy to Ambulatory Surgical Centers
CMS will review the panel’s recommendations, and the final rules will be published later in 2021.
Read More
CPAP Alternatives: Sleep Center Personalizes Treatment for Every Sleep Apnea Patient
A flow chart from Sleep 360 Sleep Diagnostic Center illustrates the OSA patient journey from referral to customized therapy.
Read More
Signifier Raises $35M to Accelerate Commercialization of eXciteOSA Therapy
Proceeds of the financing will be directed towards commercialization of eXciteOSA in core target markets, continued development of proprietary digital patient and physician interface platforms, the generation of additional clinical data to reinforce the therapeutic efficacy of eXciteOSA, and progressing reimbursement.
Read MoreFDA Gives LivaNova Approval for Aura6000 Clinical Study for Obstructive Sleep Apnea
This randomized controlled trial will take place at approximately 20 sites across the United States and will enroll a maximum of 150 adult patients with moderate to severe OSA who do not achieve results from a traditional CPAP machine or have declined its use.
Read More
Scientists Observe Vagus Nerve Stimulation Effect on Brain Activity During Sleep & Wakefulness
Vagal-evoked potentials were largest during a specific sleep stage called nonREM sleep, during which large, slow waves dominate the electrical activity of the brain.
Read More